Sid Yadav MD, FACP (@sidyadavmd) 's Twitter Profile
Sid Yadav MD, FACP

@sidyadavmd

Breast & GYN Oncologist @MayoCancerCare | Associate Professor of Oncology @MayoClinic | Research in DNA damage repair deficiencies & familial cancers.

ID: 50411679

linkhttps://www.mayoclinic.org/biographies/yadav-siddhartha-m-b-b-s/bio-20489847 calendar_today24-06-2009 19:44:14

1,1K Tweet

3,3K Takipçi

3,3K Takip Edilen

Sid Yadav MD, FACP (@sidyadavmd) 's Twitter Profile Photo
Sid Yadav MD, FACP
@sidyadavmd

20 days ago

A cheaper way to identify HRD positive tumors that might benefit from PARPi+Bev maintenance in ovarian cancer? In the PAOLA-1/ENGOT-ov25 trial (n=519), BRCA1/RAD51C methylation testing showed PFS & OS benefit with bevacizumab+olaparib maintenance. ✅ Identified ~85% of HRD+

A cheaper way to identify HRD positive tumors that might benefit from PARPi+Bev maintenance in ovarian cancer? In the PAOLA-1/ENGOT-ov25 trial (n=519), BRCA1/RAD51C methylation testing showed PFS & OS benefit with bevacizumab+olaparib maintenance. ✅ Identified ~85% of HRD+